[PHARMA] YoY Quarter Result on 31-Dec-2018 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Dec-2018 [#4]
Profit Trend
QoQ- -70.52%
YoY- -79.55%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 711,718 634,583 715,683 596,644 613,196 582,816 680,150 0.75%
PBT 125,088 -13,506 -238,474 11,940 19,866 4,069 23,717 31.90%
Tax -39,923 6,459 59,741 -7,370 2,222 -4,969 -7,676 31.59%
NP 85,165 -7,047 -178,733 4,570 22,088 -900 16,041 32.04%
-
NP to SH 85,475 -6,331 -178,598 4,437 21,700 -836 16,062 32.09%
-
Tax Rate 31.92% - - 61.73% -11.18% 122.12% 32.36% -
Total Cost 626,553 641,630 894,416 592,074 591,108 583,716 664,109 -0.96%
-
Net Worth 450,411 337,298 336,573 509,862 526,888 531,169 529,786 -2.66%
Dividend
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Div 65,466 2,614 - 5,202 15,573 7,773 18,134 23.83%
Div Payout % 76.59% 0.00% - 117.26% 71.77% 0.00% 112.90% -
Equity
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Net Worth 450,411 337,298 336,573 509,862 526,888 531,169 529,786 -2.66%
NOSH 1,309,336 261,705 261,229 260,505 259,821 259,377 259,064 30.96%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 11.97% -1.11% -24.97% 0.77% 3.60% -0.15% 2.36% -
ROE 18.98% -1.88% -53.06% 0.87% 4.12% -0.16% 3.03% -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 54.36 242.70 274.30 229.36 236.25 224.93 262.54 -23.06%
EPS 6.53 -2.42 -68.45 1.71 8.36 -0.32 6.20 0.86%
DPS 5.00 1.00 0.00 2.00 6.00 3.00 7.00 -5.44%
NAPS 0.344 1.29 1.29 1.96 2.03 2.05 2.045 -25.68%
Adjusted Per Share Value based on latest NOSH - 260,505
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 49.38 44.03 49.66 41.40 42.55 40.44 47.19 0.75%
EPS 5.93 -0.44 -12.39 0.31 1.51 -0.06 1.11 32.18%
DPS 4.54 0.18 0.00 0.36 1.08 0.54 1.26 23.79%
NAPS 0.3125 0.234 0.2335 0.3538 0.3656 0.3685 0.3676 -2.66%
Price Multiplier on Financial Quarter End Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 -
Price 0.74 5.00 2.06 2.78 4.60 5.30 6.36 -
P/RPS 1.36 2.06 0.75 1.21 1.95 2.36 2.42 -9.14%
P/EPS 11.34 -206.50 -3.01 162.99 55.02 -1,642.66 102.58 -30.69%
EY 8.82 -0.48 -33.23 0.61 1.82 -0.06 0.97 44.42%
DY 6.76 0.20 0.00 0.72 1.30 0.57 1.10 35.30%
P/NAPS 2.15 3.88 1.60 1.42 2.27 2.59 3.11 -5.96%
Price Multiplier on Announcement Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 17/02/22 17/03/21 20/02/20 21/02/19 27/02/18 21/02/17 15/02/16 -
Price 0.76 3.49 2.04 2.76 4.04 5.12 6.19 -
P/RPS 1.40 1.44 0.74 1.20 1.71 2.28 2.36 -8.32%
P/EPS 11.64 -144.14 -2.98 161.81 48.32 -1,586.88 99.84 -30.08%
EY 8.59 -0.69 -33.55 0.62 2.07 -0.06 1.00 43.06%
DY 6.58 0.29 0.00 0.72 1.49 0.59 1.13 34.09%
P/NAPS 2.21 2.71 1.58 1.41 1.99 2.50 3.03 -5.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment